This examine proposes that K2's substantial adverse effect occurrence is due, no less than partly, to distinctive JWH-018 metabolite activity in the cannabinoid 1 receptor (CB1R), and indicates that metabolites of most medication, but not the carboxy metabolite, retain in vitro As well as in vivo action at CB1Rs. AM-2201 https://kameronibqft.tkzblog.com/30996711/a-review-of-eam-2201-synthetic-cannabinoid-reddit